Vaccination against hepatitis viruses in Poland

被引:10
作者
Slusarczyk, J [1 ]
机构
[1] Natl Inst Hyg, Dept Sera & Vaccines Evaluat, PL-00791 Warsaw, Poland
关键词
hepatitis viruses; Poland; vaccination;
D O I
10.1016/S0264-410X(00)00459-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At present, two etiologic varieties of viral hepatitis (VH) can be directly vaccine-preventable: VH type A and VH type B. In addition. VH type D can be prevented indirectly through vaccination against VH-B. The first commercially available vaccine against VH-B appeared in 1981 and was human plasma-derived. After several years it has generally been replaced by a recombinant type of vaccines. The obvious benefits of vaccination against VH-B prompted its introduction into the national immunization program in Poland in 1989. At that time. vaccination was offered free of charge to high-risk groups: newborns of HBsAg-carrier mothers, health-care workers, students: at medical schools, nursing schools, medical technology schools, and caretakers at institutions for mentally retarded persons. However, similarly to the experiences of other countries. observations in Poland indicated that such a targeted strategy fails to induce major epidemiological changes. In 1989 and in 1993, the incidence of VH-B per 100 000 was 40.3 and 34.6, respectively. In addition. during these years, the incidence of V-B per 100 000 children aged 0-4 years was 20.0 and 38.4. respectively. It has been decided that vaccination against VH-B will be obligatory for all newborns beginning from 1993. Due to financial constraints, it has been introduced in three phases, and since 1996, all newborns in Poland have been vaccinated. Already in 1993, three additional risk groups have been offered vaccination: patients with chronic diseases, patients awaiting planned surgery, and persons coming into close contact with acute VH-B or chronically HBV-infected individuals. In 1999, the incidence of VH-B per 100 000 was 9.1/100 000, and it may be assumed that vaccination helped to decrease the incidence of VH-B in Poland. The country experience with vaccination against VH-A is still limited. At present, it is recommended for children and adolescents and people dealing with food distribution, as well as for several other groups of people, such as travellers or long-term visitors (soldiers, missionaries, diplomats) to the endemic regions of the world. It has also been recommended in connection with natural disasters such as floods occurring in a large area of Poland in 1997. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2384 / 2388
页数:5
相关论文
共 50 条
[41]   Indication of determination of antibodies against hepatitis C and A viruses in the protocol for the care of young immigrants [J].
Masvidal Aliberch, Rosa M. ;
Estabanell Buxo, Ana ;
Miguel Gil, Beatriz ;
Cruz Rodriguez, Cecilia ;
de Frutos Gallego, Elisa ;
Guzman Molina, Claudia ;
Riera Vidal, Dolors .
GACETA SANITARIA, 2010, 24 (04) :288-292
[42]   Comparative Seroprevalence of Hepatitis A And E Viruses in Blood Donors from Wielkopolska Region, West-Central Poland [J].
Bura, Maciej ;
Lagiedo-Zelazowska, Malgorzata ;
Michalak, Michal ;
Sikora, Jan ;
Mozer-Lisewska, Iwona .
POLISH JOURNAL OF MICROBIOLOGY, 2018, 67 (01) :113-115
[43]   VACCINATION AGAINST HEPATITIS-B IN A GENERAL-HOSPITAL IN ISRAEL - ANTIBODY LEVEL BEFORE VACCINATION AND IMMUNOGENICITY OF VACCINE [J].
KARPUCH, J ;
SCAPA, E ;
ESHCHAR, J ;
WARON, M ;
BARSHANY, S ;
SHWARTZ, T .
ISRAEL JOURNAL OF MEDICAL SCIENCES, 1993, 29 (08) :449-452
[44]   Improving Therapeutic Vaccination against Hepatitis B-Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection [J].
Knolle, Percy A. ;
Huang, Li-Rung ;
Kosinska, Anna ;
Wohlleber, Dirk ;
Protzer, Ulrike .
VACCINES, 2021, 9 (11)
[45]   Smallpox vaccination and bioterrorism with pox viruses [J].
Mayr, A .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2003, 26 (5-6) :423-430
[46]   Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea [J].
Song, Hyun Joo ;
Kim, Tae Hun ;
Song, Ji Hyun ;
Oh, Hee Jung ;
Ryu, Kum Hei ;
Yeom, Hye Jung ;
Kim, Seong-Eun ;
Jung, Hye-Kyung ;
Shim, Ki-Nam ;
Jung, Sung-Ae ;
Yoo, Kwon ;
Moon, Il-Hwan ;
Chung, Kyu Won .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (02) :218-222
[47]   Post-vaccination Immunity Against Hepatitis B Among Mongolian Adolescents and Youths [J].
Shagdarsuren, Oyu-Erdene ;
Khuyag, Ser-Od ;
Mukhtar, Yerkyebulan ;
Mandakh, Undram ;
Tsogzolbaatar, Enkh-Oyun ;
Shaarii, Shatar ;
Batsuren, Nyamsuren ;
Namdag, Bira ;
Radnaa, Otgonbayar ;
Dambadarjaa, Davaalkham .
HEPATITIS MONTHLY, 2021, 21 (12)
[48]   Spatial analysis of vaccination against Hepatitis B in pregnant women in an urban Brazilian area [J].
Rodrigues da Silva, Thales Philipe ;
Gomes, Crizian Saar ;
do Carmo, Ariene Silva ;
Mendes, Larissa Loures ;
Rezende, Edna Maria ;
Velasquez-Melendez, Gustavo ;
Matozinhos, Fernanda Penido .
CIENCIA & SAUDE COLETIVA, 2021, 26 (03) :1173-1182
[49]   Vaccination campaign against hepatitis B for 12-year-old subjects in Italy [J].
Stroffolini, T ;
Cialdea, L ;
Tosti, ME ;
Grandolfo, M ;
Mele, A .
VACCINE, 1997, 15 (05) :583-585
[50]   Approaches of the diagnosis of hepatitis viruses [J].
Kotwal, GJ .
MOLECULAR BIOTECHNOLOGY, 2000, 16 (03) :271-289